Raymond James & Associates Amyris, Inc. Transaction History

Raymond James & Associates

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$0.01 - $0.06 $6 - $36	-608 Reduced 4.1%	14,219 $0
Q3 2023 Oct 24, 2023	SELL	$0.04 - $1.17 $769 - $22,506	-19,236 Reduced 56.47%	14,827 $0
Q1 2023 Apr 14, 2023	SELL	$1.09 - $1.82 $713 - $1,192	-655 Reduced 1.89%	34,063 $46,000
Q4 2022 Feb 08, 2023	SELL	$1.52 - $3.39 $8,580 - $19,136	-5,645 Reduced 13.99%	34,718 $53,000
Q3 2022 Oct 25, 2022	SELL	$1.7 - $4.05 $33,646 - $80,157	-19,792 Reduced 32.9%	40,363 $118,000
Q2 2022 Aug 12, 2022	BUY	$1.6 - $5.07 $32,985 - $104,523	20,616 Added 52.14%	60,155 $111,000
Q1 2022 May 11, 2022	BUY	$3.92 - $5.86 $60,897 - $91,035	15,535 Added 64.72%	39,539 $172,000
Q4 2021 Feb 08, 2022	SELL	$5.0 - $14.85 $16,680 - $49,539	-3,336 Reduced 12.2%	24,004 $130,000
Q3 2021 Nov 02, 2021	BUY	$12.13 - $16.99 $331,634 - $464,506	27,340 New	27,340 $375,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.